Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.

On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.

Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.

🛡️ immunology

Tirzepatide preserves hematopoietic stem and progenitor cycling while remodeling inflammatory monocytes in obese mice

This study demonstrates that in obese mice, tirzepatide-induced weight loss selectively remodels inflammatory monocytes while preserving hematopoietic stem and progenitor cell cycling, thereby avoiding the broad blood lineage suppression observed with caloric restriction.

Krah, N. M., Gonzalez-Alvarado, E., Urs, A. P., Goda, C., Bustos, Y., Marvin, J. E., Weaver, B. D., Gygi, S., Toshniwal (…)2026-09-04
🛡️ immunology

Modeling how memory CD8 T cells can elicit post-treatment control of HIV infection

By combining mathematical modeling with SIV data, this study proposes that antiretroviral therapy preserves memory CD8 T cell functionality by halting antigenic stimulation, thereby enabling robust recall responses that can establish post-treatment control of HIV independently of the latent reservoir size.

Vemparala, B., Passaes, C., Desjardins, D., Monceaux, V., Lemaitre, J., Melard, A., Charre, C., Gourves, M., Dimant, N. (…)2026-09-04
🛡️ immunology

Enhancing Mycobacterial Clearance via Heterologous BCG Prime Boost Strategy Using Recombinant Mycobacterium smegmatis

This study demonstrates that a heterologous prime-boost strategy using a recombinant *Mycobacterium smegmatis* expressing Ag85B and ESAT-6, particularly when adjuvanted with oat-derived β\beta-glucan, significantly enhances BCG-induced immunity to achieve complete systemic clearance of *Mycobacterium tuberculosis* in mice, outperforming repeated BCG vaccination which offers no additional protection.

Ji, H., Kang, K., Kim, J., Kwon, Y., Kang, H., Choi, U., Kang, J., CHOI, G.2026-09-03
🛡️ immunology

Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery and enhanced humoral immune responses

This study demonstrates that atomic layer deposition (ALD) can be used to coat core-shell microparticle vaccines with a programmable nanoscopic alumina shell, enabling sustained antigen release that significantly enhances germinal center expansion, antibody affinity, and long-lived plasma cell generation compared to traditional bolus vaccination.

Chaudhary, N., Coleman, H. J., Paolone, E. V., Yu, J., Ledbetter, A. W., Lemnios, A. A., Walsh, A. A., Suh, H., Wang, A. (…)2026-09-02
🛡️ immunology

A mechanistic basis for CD8+ T cell expansion sensitivity as a predictor of HIV post-treatment control

This study uses mechanistic modeling to demonstrate that the expansion sensitivity of CD8+ T cells provides the underlying biological basis for why high levels of Ki-67+ and TCF-1+ cells predict successful post-treatment control of HIV by establishing lower viral set points.

Phan, T., Pagane, N., Kreig, J. A. F., Marc, A., Locke, M., Peluso, M. J., Sandel, D. A., Deitchman, A. N., Rutishauser (…)2026-09-01
🛡️ immunology

Isolation and characterisation of Nipah virus neutralising candidate therapeutic monoclonal antibodies from an mRNA-immunised pig

This study demonstrates the utility of an mRNA-immunised pig model for isolating novel Nipah virus neutralising monoclonal antibodies that target distinct epitopes on the G glycoprotein, with a specific candidate (mAb A2) showing enhanced therapeutic potential when combined with the existing standard mAb m102.4 to achieve complete protection against lethal viral challenge.

Pedrera, M., Pipatpadungsin, N., Kobasa, D., Elrefaey, A. M. E., Holzer, B., McLean, R. K., Warner, B., Vendramelli, R. (…)2026-08-30